How many insider declarations has Abrams Michael S filed?

Abrams Michael S has filed 2 public insider declarations with SEC (Form 4).

What is Abrams Michael S's role?

Abrams Michael S's reported role is not specified by the regulator across the filings.

Which companies does Abrams Michael S report trades for?

Abrams Michael S reports trades for Arch Therapeutics, Inc..

What is Abrams Michael S's declared buy vs sell volume?

Across the available history, declared buys total 3k€ and disposals 0.

← Executives ★ Sign in to follow

AM

Abrams Michael S

·SEC (Form 4)

Arch Therapeutics, Inc.

0

Total declarations

0

Company

€2,610

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the detailed record of transactions filed by Abrams Michael S. Insider active across 1 company, notably Arch Therapeutics, Inc.. Cumulatively, 2 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €3k. History available since 31 August 2023. The latest transaction was disclosed on 31 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Abrams Michael S

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Arch Therapeutics, Inc. (US)

Declarations2 total

▲

ABRAMS MICHAEL S

CHIEF FINANCIAL OFFICERExecutives31 Aug 2023Arch Therapeutics, Inc.

$2,83046SEC ↗

10,292 shares@ US$0.275100.0% of flowCommon StockSEC:0001437749-23-025515:0

Canonical exit: 29 Nov 2023 (T+90)

◆